Synfacts, Table of Contents

Synfacts 2024; 20(07): 0759
DOI: 10.1055/s-0043-1774882

Innovative Drug Discovery and Development

TNG908, a Clinical Candidate for PRMT5 Inhibition Exploiting Synthetic Lethality with MTAP

Contributor(s):

Antonia F. Stepan (Roche)

,

Seong Heon Kim (Hyundai Pharm)